Biotech · Public company · Brisbane, CA, US
Nurix Therapeutics, Inc.
Ticker NRIX · SEC CIK 0001549595
Track this companyFree. Adds Nurix Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials106 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline16
- NX-5948Phase 3 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PirtobrutinibPhase 3 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- NX-5948Phase 2 · Chronic Lymphocytic Leukemia (CLL)ClinicalTrials.gov · fetched Nov 12, 2026
- obinutuzumabPhase 2 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- rituximabPhase 2 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- venetoclaxPhase 2 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- DigoxinPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Drug Product De-TIL-0255Phase 1 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- EsomeprazolePhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- FamotidinePhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- IPPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- NX-1607Phase 1 · Ovarian Cancer, EpithelialClinicalTrials.gov · fetched Nov 12, 2026
- NX-2127Phase 1 · Chronic Lymphocytic Leukemia (CLL)ClinicalTrials.gov · fetched Nov 12, 2026
- NX-5948Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 1 · Ovarian Cancer, EpithelialClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Study of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesPHASE1_PHASE2 · RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07520006 · fetched Nov 12, 2026
- Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLLPHASE3 · RECRUITING · started Aug 3, 2026ClinicalTrials.gov NCT07516093 · fetched Nov 12, 2026
- A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)PHASE2 · RECRUITING · started Oct 15, 2025ClinicalTrials.gov NCT07221500 · fetched Nov 12, 2026
- A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy VolunteersPHASE1 · COMPLETED · started Nov 30, 2024ClinicalTrials.gov NCT06717269 · fetched Nov 12, 2026
- Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948PHASE1 · COMPLETED · started Nov 1, 2024ClinicalTrials.gov NCT06691828 · fetched Nov 12, 2026
- A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult SubjectsPHASE1 · COMPLETED · started Aug 20, 2024ClinicalTrials.gov NCT06593457 · fetched Nov 12, 2026
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesPHASE1 · RECRUITING · started Apr 13, 2022ClinicalTrials.gov NCT05131022 · fetched Nov 12, 2026
- A Study of DeTIL-0255 in Adults With Advanced MalignanciesPHASE1 · TERMINATED · started Dec 22, 2021ClinicalTrials.gov NCT05107739 · fetched Nov 12, 2026
- A Study of NX-1607 in Adults With Advanced MalignanciesPHASE1 · RECRUITING · started Sep 29, 2021ClinicalTrials.gov NCT05107674 · fetched Nov 12, 2026
- A Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesPHASE1 · RECRUITING · started May 5, 2021ClinicalTrials.gov NCT04830137 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Oct 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 13, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jul 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Apr 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 6, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Jan 28, 2026 · fetched Nov 12, 2026